GENE ONLINE|News &
Opinion
Blog

2024-03-28|

Previewing AACR 2024 With Select Pre-Meeting Highlights

by Bernice Lottering
Share To
Source: AACR

American Association for Cancer Research, 2024 Annual Meeting

The AACR Annual Meeting 2024 is scheduled to take place at the San Diego Convention Center in California, running from April 5th to April 10th. Taking place every year, the AACR Annual Meeting serves as the central hub for the cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the most recent breakthroughs in cancer science and medicine. This year’s rich program spans the breadth of oncology, encompassing advancements in population science, prevention, cancer biology, translational and clinical studies, as well as survivorship and advocacy. It showcases the innovative work of leading researchers and medical professionals from institutions across the globe.

GeneOnline will conduct a special report on the AACR. The following table is a preview of some of the exciting content to be shared.

2024 AACR Select Research Highlights by Oscar Wu, GeneOnline

With approximately 22 000 attendees, 630 speakers and 450 exhibitors, present throughout the 6 day conference, the AACR Annual meeting promises to be a rich source of information within the oncology field. Featuring educational conferences, specialized courses, workshop lectures, special forums and educational materials, this ground-breaking comprehensive content is something not to be missed.

Reference: AACR Official Website

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
EVENT
Scroll to Top